Skip to content
10-Q

Quarterly Report

SCOPUS BIOPHARMA INC.

0001410578-22-003519

← back to feed
Filed
Nov 21, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 21, 2022 21.09M sh
Shares Diluted Q3 2022 · Sep 30, 2022 21.09M sh
Shares Diluted Q3 2022 · Sep 30, 2022 21.09M sh
Shares Diluted Q3 2022 · Sep 30, 2021 17.15M sh
Shares Diluted Q3 2022 · Sep 30, 2021 16.55M sh
Capex Q3 2022 · Sep 30, 2022 $1.55K
Capex Q3 2022 · Sep 30, 2021 $2K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$7.7M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$7.28M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $310.82K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $7.94M
Stockholders Equity Q3 2022 · Sep 30, 2022 −$5.5M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$3.7M
Stockholders Equity Q3 2022 · Dec 31, 2021 $4.02M
Stockholders Equity Q3 2022 · Sep 30, 2021 $1.79M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$1.98M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$1.83M
Current Assets Q3 2022 · Sep 30, 2022 $413.18K
Current Assets Q3 2022 · Dec 31, 2021 $8.18M
Total Assets Q3 2022 · Sep 30, 2022 $415.68K
Total Assets Q3 2022 · Dec 31, 2021 $8.19M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.09
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.47
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.08
Eps Diluted Q3 2022 · Sep 30, 2021 −$1.23
Eps Basic Q3 2022 · Sep 30, 2022 −$0.09
Eps Basic Q3 2022 · Sep 30, 2022 −$0.47
Eps Basic Q3 2022 · Sep 30, 2021 −$0.08
Eps Basic Q3 2022 · Sep 30, 2021 −$1.23
Sga Expense Q3 2022 · Sep 30, 2022 $981.34K
Sga Expense Q3 2022 · Sep 30, 2022 $7.94M
Sga Expense Q3 2022 · Sep 30, 2021 $2.68M
Sga Expense Q3 2022 · Sep 30, 2021 $6.23M
Rd Expense Q3 2022 · Sep 30, 2022 $917.27K
Rd Expense Q3 2022 · Sep 30, 2022 $1.94M
Rd Expense Q3 2022 · Sep 30, 2021 $77.53K
Rd Expense Q3 2022 · Sep 30, 2021 $14.89M
Net Income Q3 2022 · Sep 30, 2022 −$1.9M
Net Income Q3 2022 · Sep 30, 2022 −$9.88M
Net Income Q3 2022 · Sep 30, 2021 −$1.4M
Net Income Q3 2022 · Sep 30, 2021 −$20.43M
Operating Income Q3 2022 · Sep 30, 2022 −$1.9M
Operating Income Q3 2022 · Sep 30, 2022 −$9.88M
Operating Income Q3 2022 · Sep 30, 2021 −$2.76M
Operating Income Q3 2022 · Sep 30, 2021 −$21.12M
Revenue Q3 2022 · Sep 30, 2022 $0
Revenue Q3 2022 · Sep 30, 2022 $0
Revenue Q3 2022 · Sep 30, 2021 $0
Revenue Q3 2022 · Sep 30, 2021 $0